Sharemaestro company-news research for Aurinia Pharmaceuticals Inc (AUPH), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
NASDAQ
United States
Provisional evidence
Company news sentiment
AUPH news sentiment
Aurinia Pharmaceuticals Inc
Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.
30-day score50Neutral is 50
Early balanced news score
17/100 evidence confidence
100% direct company focus
6 current stories across 5 publishers
Current company news
Early balanced news score
6 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.
Observed headline tone50/100
→
Reliability-adjusted score50/100
Latest source headline
Aurinia Pharmaceuticals (NASDAQ:AUPH) Downgraded by Wall Street Zen to Buy
MarketBeat · 08 Aug 2026 05:40 · Source lookup
Freshness, source quality and evidence depth temper uncertain readings toward 50; confidence remains a separate reliability measure.
What supports the score
6 current stories are mapped specifically to AUPH.
The read spans 5 publishers rather than depending on one outlet.
What limits the score
The stories agree, but freshness-weighted evidence is only 0.030.
Evidence confidence is 17/100, below the threshold for a firm classification.
50/100
News scoreEarly balanced news score
17/100
Confidencethin evidence
100%/100
Company news6 company stories
100/100
Story agreement0/100 difference
News history
Daily score and story count over 30 days
15 Jul30 Jul13 Aug
News scoreStory count50 baseline
Confidence
How reliable the score is
Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.
Amount of evidence1
0.03 after freshness weightingSource breadth100
5 independent publishersCompany relevance100
share tied directly to this companyFreshness19
recency-weighted evidenceAgreement100
how closely stories agreePublisher mix57
less reliance on one publisherPrice and news history
News score and weekly price over 26 weeks
Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.
One scoring method across the chart.Stored company headlines are recalculated at each weekly point with the current 30-day freshness weighting. Old published snapshots are left unchanged.
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
WeekNews scoreCloseWeekly move
07 Aug 202650USD 15.85+6.5%
31 Jul 202650USD 14.88-3.1%
24 Jul 202650USD 15.35-3.8%
17 Jul 202651USD 15.96+1.1%
10 Jul 202650USD 15.78+1.1%
03 Jul 202650USD 15.61-9.4%
26 Jun 202650USD 17.23+4.7%
Provisional evidence
News subjects
What is shaping the score
Market update504 stories · 67%
Earnings502 stories · 33%
Source mix
Where the evidence comes from
Quartr502 stories · 33%
simplywall.st601 stories · 17%
MarketBeat501 stories · 17%
TradingView501 stories · 17%
TradingKey501 stories · 17%
Recurring subjects
Subjects appearing most often
Topic structure will appear when classified tags are present in the current feed.
Earlier readings
How the score has changed
Past and present use the same method.Each point recalculates the previous 30 days of stored company headlines with today's scoring rules. The original stored snapshots remain unchanged.
22 Jun50 neutral13 Aug 18:46
ConstructiveBalanced or withheldCautious
Changes in the stored score
Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.
| Observed | Score | Move | Confidence | Stories | Status |
|---|---|---|---|---|---|
| 13 Aug 18:46 | 50 | +0 | 17/100 (-6) | 6 (-2) | Provisional |
| 08 Aug 23:59 | 50 | +0 | 23/100 (-3) | 8 (0) | Provisional |
| 02 Aug 23:59 | 50 | +0 | 26/100 (+2) | 8 (-2) | Provisional |
| 29 Jul 23:59 | 50 | +0 | 24/100 (-2) | 10 (-1) | Provisional |
| 23 Jul 23:59 | 50 | +0 | 26/100 (+2) | 11 (-1) | Provisional |
| 19 Jul 23:59 | 50 | -1 | 24/100 (-2) | 12 (+1) | Provisional |
| 17 Jul 23:59 | 51 | +1 | 26/100 (0) | 11 (+1) | Provisional |
| 14 Jul 23:59 | 50 | +0 | 26/100 (+4) | 10 (+1) | Provisional |
Source headlines
The news behind the score
Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.
#150Tone
MarketBeatDirect company coverageScored from headlineSource lookup
Aurinia Pharmaceuticals (NASDAQ:AUPH) Downgraded by Wall Street Zen to Buy
- Published
- 08 Aug 2026 05:40
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- How it is used
- Direct company coverage
- Weighted influence
- High · 26.1% · 5.5d old
- Duplicates
- 2 consolidated
#250Tone
TradingViewDirect company coverageScored from headlineSource lookup
Aurinia Pharmaceuticals Inc Revenue Breakdown – NASDAQ:AUPH
- Published
- 02 Aug 2026 14:09
- News subject
- Earnings
- Why this score
- No clear positive or negative phrase
- How it is used
- Direct company coverage
- Weighted influence
- High · 58.2% · 11.2d old
- Duplicates
- 1 consolidated
#350Tone
TradingKeyDirect company coverageScored from headlineSource lookup
AUPH|Aurinia Pharmaceuticals Inc|Price:14.980|Chg%:-0.240
- Published
- 29 Jul 2026 12:27
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- How it is used
- Direct company coverage
- Weighted influence
- Low · 0.9% · 15.3d old
- Duplicates
- 2 consolidated
#450Tone
QuartrDirect company coverageScored from headlineSource lookup
Aurinia Pharmaceuticals (AUPH) Q1 2026 earnings summary
- Published
- 23 Jul 2026 17:03
- News subject
- Earnings
- Why this score
- No clear positive or negative phrase
- How it is used
- Direct company coverage
- Weighted influence
- Medium · 14.8% · 21.1d old
- Duplicates
- 2 consolidated
#550Tone
QuartrDirect company coverageScored from headlineSource lookup
Aurinia Pharmaceuticals (AUPH) Jefferies 2024 Global Healthcare Conference Summary
- Published
- 19 Jul 2026 06:34
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- How it is used
- Direct company coverage
- Weighted influence
- Low · <0.1% · 25.5d old
- Duplicates
- 1 consolidated
#660Tone
simplywall.stDirect company coverageScored from headlineSource lookup
Crinetics Pharmaceuticals (CRNX) Stock Looks Fully Valued While Returns Stay Very Strong
- Published
- 17 Jul 2026 17:44
- News subject
- Market update
- Why this score
- Positive financial language
- How it is used
- Direct company coverage
- Weighted influence
- Low · <0.1% · 27.0d old
- Duplicates
- 1 consolidated
Earlier company news
AUPH news archive
Stored newest first for historical research. These older headlines are retained for reference and do not contribute to the current sentiment gauge above. Where an early legacy import did not retain its canonical URL, the headline links to an exact publisher-aware source lookup instead of inventing an article address.
Jul
25
2026
TradingKeyArchivedLegacy headline · tone unscoredLegacy source lookup
AUPH|Aurinia Pharmaceuticals Inc|Price:15.400|Chg%:+0.160
- Published
- 25 Jul 2026 17:18
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
20
2026
QuartrArchivedLegacy headline · tone unscoredLegacy source lookup
Aurinia Pharmaceuticals (AUPH) Q4 2024 earnings summary
- Published
- 20 Jul 2026 22:40
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
14
2026
Market sourceArchivedLegacy headline · tone unscoredLegacy source lookup
Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks
- Published
- 14 Jul 2026 18:08
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
13
2026
SahmArchivedLegacy headline · tone unscoredLegacy source lookup
Is Aurinia Pharmaceuticals (AUPH) Using Combination LN Trials to Redefine Its LUPKYNIS Strategy?
- Published
- 13 Jul 2026 04:28
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
04
2026
Market sourceArchivedLegacy headline · tone unscoredLegacy source lookup
Aurinia (AUPH) Upgraded to Strong Buy: Here's Why
- Published
- 4 Jul 2026 05:59
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
03
2026
Ad-hoc-news.deArchivedLegacy headline · tone unscoredLegacy source lookup
Aurinia Pharmaceuticals explores long-term growth. Investor focus on autoimmune portfolio and US mar
- Published
- 3 Jul 2026 09:52
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
02
2026
FinvizArchivedLegacy headline · tone unscoredLegacy source lookup
AUPH - Aurinia Pharmaceuticals Inc Latest SEC Filings
- Published
- 2 Jul 2026 08:19
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
30
2026
Market sourceArchivedLegacy headline · tone unscoredLegacy source lookup
Is Aurinia Pharmaceuticals Inc. (AUPH) A Good Stock To Buy Now?
- Published
- 30 Jun 2026 22:25
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
29
2026
TradingViewArchivedLegacy headline · tone unscoredLegacy source lookup
IKAP Forecast — Price Target — Prediction for 2027
- Published
- 29 Jun 2026 16:22
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
25
2026
Market sourceArchivedLegacy headline · tone unscoredLegacy source lookup
Aurinia (AUPH) Moves 6.5% Higher: Will This Strength Last?
- Published
- 25 Jun 2026 05:54
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
23
2026
Investing.comArchivedLegacy headline · tone unscoredLegacy source lookup
Aurinia Pharmaceuticals stock hits 52-week high at 17.44 USD
- Published
- 23 Jun 2026 09:57
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
22
2026
Stock Traders DailyArchivedLegacy headline · tone unscoredLegacy source lookup
Understanding Momentum Shifts in (AUPH)
- Published
- 22 Jun 2026 21:13
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
How the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
It measures news already published. It is not a forecast, recommendation or price target.